Biological Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00005853 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: etanercept

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]